Related Experiment Videos
[Antioxidant therapy in ischemic stroke]
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|November 18, 2000
Summary
Emoxipin, an antioxidant drug, improved clinical outcomes for moderate ischemic strokes. Combined with carnosine, it enhances antioxidant activity and patient recovery in cerebral circulation disorders.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Context:
- Ischemic disorders of cerebral circulation, including lacunar and cardioembolic strokes, pose significant health challenges.
- Oxidative stress plays a critical role in the pathophysiology of cerebral ischemia.
- Existing treatments for ischemic stroke have limitations, necessitating novel therapeutic approaches.
Purpose:
- To investigate the therapeutic efficacy of emoxipin, a synthetic antioxidant, in patients with ischemic cerebrovascular disorders.
- To evaluate the protective effects of carnosine against experimental acute hypobaric hypoxia and cerebral ischemia in rats.
- To determine the potential of combined emoxipin and carnosine therapy for ischemic cerebrovascular diseases.
Summary:
- Emoxipin demonstrated a beneficial clinical effect in patients with moderate lacunar and cardioembolic strokes.
- Treatment with emoxipin led to increased endogenous antioxidant activity and improved the clinical status of patients.
- Carnosine exhibited a protective effect in experimental models of acute hypobaric hypoxia and cerebral ischemia in rats.
Impact:
- The findings support the recommendation of emoxipin and carnosine for combined treatment of ischemic cerebrovascular disorders.
- This research contributes to the development of neuroprotective strategies for stroke patients.
- The study highlights the potential of antioxidant therapies in managing ischemic brain injury.